Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6197
Source ID: NCT01431807
Associated Drug: Syr-472
Title: Long-term Study of SYR-472
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: SYR-472
Outcome Measures: Primary: Adverse events, 52 weeks. |
Sponsor/Collaborators: Sponsor: Takeda
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 680
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2011-09-01
Completion Date: 2013-06-01
Results First Posted:
Last Update Posted: 2023-12-14
Locations: Akita-shi, Akita, Japan|Kisarazu-shi, Chiba, Japan|Fukuoka-shi, Fukuoka, Japan|Munakata-shi, Fukuoka, Japan|Koriyama-shi, Fukushima, Japan|Gihu-shi, Gihu, Japan|Fukuyama-shi, Hiroshima, Japan|Hiroshima-shi, Hiroshima, Japan|Eniwa-shi, Hokkaido, Japan|Ishikari-shi, Hokkaido, Japan|Nakagawa-gun, Hokkaido, Japan|Obihiro-shi, Hokkaido, Japan|Sapporo-shi, Hokkaido, Japan|Kobe-shi, Hyogo, Japan|Mito-shi, Ibaragi, Japan|Naka-shi, Ibaragi, Japan|Takamatsu-shi, Kagawa, Japan|Sagamihara-shi, Kanagawa, Japan|Yokohama-shi, Kanagawa, Japan|Kumamoto-shi, Kumamoto, Japan|Tamana-shi, Kumamoto, Japan|Kyoto-shi, Kyoto, Japan|Nagano-shi, Nagano, Japan|Nagawaki-shi, Nagasaki, Japan|Oita-shi, Oita, Japan|Mino-shi, Osaka, Japan|Osaka-shi, Osaka, Japan|Sakai-shi, Osaka, Japan|Ageo-shi, Saitama, Japan|Kawaguchi-shi, Saitama, Japan|Koshigaya-shi, Saitama, Japan|Kuki-shi, Saitama, Japan|Saitama-shi, Saitama, Japan|Suntou-gun, Shizuoka, Japan|Oyama-shi, Tochigi, Japan|Chuo-ku, Tokyo, Japan|Koganei-shi, Tokyo, Japan|Meguro-ku, Tokyo, Japan|Shibuya-ku, Tokyo, Japan|Tama-shi, Tokyo, Japan|Tiyoda-ku, Tokyo, Japan
URL: https://clinicaltrials.gov/show/NCT01431807

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress